WHO recommendation on oxytocin for prevention of delay in labour in women with epidural analgesia

Pregnant woman receiving intravenous oxytocin.

WHO recommendation on oxytocin for prevention of delay in labour in women with epidural analgesia

 

Recommendation

The use of oxytocin for prevention of delay in labour in women receiving epidural analgesia is not recommended.

(Not recommended)

 

Publication history

First published: February 2018

Updated: No update planned

Assessed as up-to-date: February 2018 

 

Remarks

  • This recommendation has been integrated from the WHO recommendations for augmentation of labour, in which the GDG for that guideline determined it to be a conditional recommendation based on low-quality evidence.  
  • Augmentation with oxytocin should be performed when indicated as treatment of confirmed delay of labour progress in women receiving epidural analgesia.
  • The evidence supporting this recommendation can be found in the source guideline document, available at:

WHO recommendation on the use of oxytocin for prevention of delay in labour in women receiving epidural analgesia

http://who.int/iris/bitstream/10665/112826/1/WHO_RHR_14.15_eng.pdf

 

Related links

WHO recommendations on intrapartum care for a positive childbirth experience

(2018) - full document and evidence tables

Managing Complications in Pregnancy and Childbirth: A guide for midwives and doctors

Pregnancy, Childbirth, Postpartum and Newborn Care: A guide for essential practice

WHO Programmes: Sexual and Reproductive health

Maternal Health